4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide

C99H101N23O8S — CID 159644696

IUPAC4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide
SMILESCC(C)(C)c1ccc(NC(=O)C2(c3ccc(-c4cnc(N)nc4)cc3)CCOCC2)cc1.Cn1cc(-c2ccc(NC(=O)C3(c4ccc(-c5cnc(N)nc5)cc4)CCOCC3)nc2)cn1.Cn1cnc(-c2ccc(NC(=O)C3(c4ccc(-c5cnc(N)nc5)cc4)CCOCC3)nc2)c1.Nc1ncc(-c2ccc(C3(C(=O)Nc4ccc5ncsc5c4)CCOCC3)cc2)cn1
InChIInChI=1S/C26H30N4O2.2C25H25N7O2.C23H21N5O2S/c1-25(2,3)20-8-10-22(11-9-20)30-23(31)26(12-14-32-15-13-26)21-6-4-18(5-7-21)19-16-28-24(27)29-17-19;1-32-16-20(15-30-32)18-4-7-22(27-12-18)31-23(33)25(8-10-34-11-9-25)21-5-2-17(3-6-21)19-13-28-24(26)29-14-19;1-32-15-21(30-16-32)18-4-7-22(27-12-18)31-23(33)25(8-10-34-11-9-25)20-5-2-17(3-6-20)19-13-28-24(26)29-14-19;24-22-25-12-16(13-26-22)15-1-3-17(4-2-15)23(7-9-30-10-8-23)21(29)28-18-5-6-19-20(11-18)31-14-27-19/h4-11,16-17H,12-15H2,1-3H3,(H,30,31)(H2,27,28,29);2*2-7,12-16H,8-11H2,1H3,(H2,26,28,29)(H,27,31,33);1-6,11-14H,7-10H2,(H,28,29)(H2,24,25,26)
InChIKeyMQUPHDMIHXPVPI-UHFFFAOYSA-N
MW1773.12 g/mol
LogP15.15
Rot. Bonds18

About 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide

4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide (PubChem CID 159644696) has the molecular formula C99H101N23O8S and a molecular weight of 1773.12 g/mol. Its IUPAC name is 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide.

Molecular Properties

Compound Name4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide
PubChem CID159644696
Molecular FormulaC99H101N23O8S
Molecular Weight1773.12 g/mol
Exact Mass1771.79
IUPAC Name4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide
SMILESCC(C)(C)c1ccc(NC(=O)C2(c3ccc(-c4cnc(N)nc4)cc3)CCOCC2)cc1.Cn1cc(-c2ccc(NC(=O)C3(c4ccc(-c5cnc(N)nc5)cc4)CCOCC3)nc2)cn1.Cn1cnc(-c2ccc(NC(=O)C3(c4ccc(-c5cnc(N)nc5)cc4)CCOCC3)nc2)c1.Nc1ncc(-c2ccc(C3(C(=O)Nc4ccc5ncsc5c4)CCOCC3)cc2)cn1
InChIInChI=1S/C26H30N4O2.2C25H25N7O2.C23H21N5O2S/c1-25(2,3)20-8-10-22(11-9-20)30-23(31)26(12-14-32-15-13-26)21-6-4-18(5-7-21)19-16-28-24(27)29-17-19;1-32-16-20(15-30-32)18-4-7-22(27-12-18)31-23(33)25(8-10-34-11-9-25)21-5-2-17(3-6-21)19-13-28-24(26)29-14-19;1-32-15-21(30-16-32)18-4-7-22(27-12-18)31-23(33)25(8-10-34-11-9-25)20-5-2-17(3-6-20)19-13-28-24(26)29-14-19;24-22-25-12-16(13-26-22)15-1-3-17(4-2-15)23(7-9-30-10-8-23)21(29)28-18-5-6-19-20(11-18)31-14-27-19/h4-11,16-17H,12-15H2,1-3H3,(H,30,31)(H2,27,28,29);2*2-7,12-16H,8-11H2,1H3,(H2,26,28,29)(H,27,31,33);1-6,11-14H,7-10H2,(H,28,29)(H2,24,25,26)
InChIKeyMQUPHDMIHXPVPI-UHFFFAOYSA-N
XLogP15.15
TPSA434.83 Ų
H-Bond Donors8
H-Bond Acceptors28
Rotatable Bonds18
Heavy Atoms131
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001773.12
LogP ≤ 515.15
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1028

Analyze 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide?
The IUPAC name of 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide (CID 159644696) is 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide.
What is the SMILES notation for 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide?
The canonical SMILES for 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide is CC(C)(C)c1ccc(NC(=O)C2(c3ccc(-c4cnc(N)nc4)cc3)CCOCC2)cc1.Cn1cc(-c2ccc(NC(=O)C3(c4ccc(-c5cnc(N)nc5)cc4)CCOCC3)nc2)cn1.Cn1cnc(-c2ccc(NC(=O)C3(c4ccc(-c5cnc(N)nc5)cc4)CCOCC3)nc2)c1.Nc1ncc(-c2ccc(C3(C(=O)Nc4ccc5ncsc5c4)CCOCC3)cc2)cn1.
What is the InChIKey of 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide?
The InChIKey is MQUPHDMIHXPVPI-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H30N4O2.2C25H25N7O2.C23H21N5O2S/c1-25(2,3)20-8-10-22(11-9-20)30-23(31)26(12-14-32-15-13-26)21-6-4-18(5-7-21)19-16-28-24(27)29-17-19;1-32-16-20(15-30-32)18-4-7-22(27-12-18)31-23(33)25(8-10-34-11-9-25)21-5-2-17(3-6-21)19-13-28-24(26)29-14-19;1-32-15-21(30-16-32)18-4-7-22(27-12-18)31-23(33)25(8-10-34-11-9-25)20-5-2-17(3-6-20)19-13-28-24(26)29-14-19;24-22-25-12-16(13-26-22)15-1-3-17(4-2-15)23(7-9-30-10-8-23)21(29)28-18-5-6-19-20(11-18)31-14-27-19/h4-11,16-17H,12-15H2,1-3H3,(H,30,31)(H2,27,28,29);2*2-7,12-16H,8-11H2,1H3,(H2,26,28,29)(H,27,31,33);1-6,11-14H,7-10H2,(H,28,29)(H2,24,25,26).
What are the key properties of 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide?
4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide has a molecular weight of 1773.12 g/mol, XLogP of 15.15, 18 rotatable bonds, 8 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(1,3-benzothiazol-6-yl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-(4-tert-butylphenyl)oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylimidazol-4-yl)-2-pyridinyl]oxane-4-carboxamide;4-[4-(2-aminopyrimidin-5-yl)phenyl]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]oxane-4-carboxamide is sourced from PubChem (CID 159644696), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).